Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptors (TLRs) are a class of pattern recognition receptors (PRRs) expressed on the surface and within intestinal epithelial cells. They detect microbial components (such as lipopolysaccharide, flagellin, nucleic acids) derived from commensal and pathogenic microbes. Upon recognition, they initiate intracellular signaling pathways leading to cytokine and chemokine expression, epithelial cell proliferation, and antimicrobial peptide production, playing crucial roles in maintaining barrier homeostasis and mucosal immunity. TLR signaling is tightly regulated to maintain tolerance to commensals while safeguarding against pathogens; dysregulation is implicated in inflammatory bowel disease and other chronic inflammatory conditions of the gut.
Agonists: Activate TLR signaling, inducing host defense genes and cytokine production. Antagonists: Block TLR-mediated inflammation or immune activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor (intestinal epithelial cell) (TLR (intestinal epithelial cell)).